|
US2909462A
(en)
|
1955-12-08 |
1959-10-20 |
Bristol Myers Co |
Acrylic acid polymer laxative compositions
|
|
US2993836A
(en)
|
1958-02-20 |
1961-07-25 |
Dow Chemical Co |
Sustained release tablets
|
|
US3079303A
(en)
|
1958-12-11 |
1963-02-26 |
Smith Kline French Lab |
Basic tablet granulation and process of using same
|
|
US3056143A
(en)
|
1959-09-04 |
1962-10-02 |
Foster Benton |
Apparatus for automatically flushing a toilet bowl or the like
|
|
BE604564A
(forum.php)
|
1960-06-06 |
|
|
|
|
US3133863A
(en)
|
1961-03-10 |
1964-05-19 |
Strong Cobb Arner Inc |
Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
|
|
US3147187A
(en)
|
1962-09-10 |
1964-09-01 |
Don Hall Lab |
Sustained release pharmaceutical
|
|
US3388041A
(en)
|
1964-01-27 |
1968-06-11 |
Richardson Merrell Inc |
High dosage sustained release tablet
|
|
GB1097207A
(en)
|
1964-08-24 |
1967-12-29 |
Collett & Co As |
Process for the preparation of sustained action tablets
|
|
US3456049A
(en)
|
1965-05-25 |
1969-07-15 |
Ciba Geigy Corp |
Gradual-release tablet
|
|
US3726690A
(en)
|
1965-10-22 |
1973-04-10 |
Kelco Co |
Acidified food products containing xanthomonas colloid
|
|
US3864469A
(en)
|
1967-12-16 |
1975-02-04 |
Hoechst Ag |
Xanthines in pharmaceutical preparations and for stabilization of vitamins
|
|
US3574820A
(en)
|
1968-01-08 |
1971-04-13 |
Upjohn Co |
Medicinal dosage forms of unpolymerized thiolated gelatin with a cross-linking accelerating agent providing slowly released medication from a swollen matrix
|
|
US3627583A
(en)
|
1969-04-29 |
1971-12-14 |
Sucrest Corp |
Direct compression vehicles
|
|
US3639169A
(en)
|
1969-04-29 |
1972-02-01 |
Sucrest Corp |
Direct compression vehicles and method therefor
|
|
US3629393A
(en)
|
1969-09-11 |
1971-12-21 |
Nikken Chemicals Co Ltd |
Release-sustaining-tablet
|
|
US3963822A
(en)
|
1969-09-12 |
1976-06-15 |
Noma Lites Canada Limited |
Method of molding electrical lamp sockets
|
|
GB1359643A
(en)
|
1970-09-28 |
1974-07-10 |
Controlled Medications |
Controlled release medicament
|
|
US4072535A
(en)
|
1970-12-28 |
1978-02-07 |
A. E. Staley Manufacturing Company |
Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
|
|
FR2138492A1
(en)
|
1971-05-27 |
1973-01-05 |
Cerm Cent Europ Rech Mauvernay |
Basic aluminium salts of gum xanthane - pharmaceutical gelling agents
|
|
DE2130545A1
(de)
|
1971-06-19 |
1972-12-21 |
Merck Patent Gmbh |
Pharmazeutischer Formkoerper
|
|
US3773920A
(en)
|
1971-07-14 |
1973-11-20 |
Nikken Chemicals Co Ltd |
Sustained release medicinal composition
|
|
US3836618A
(en)
|
1971-12-23 |
1974-09-17 |
American Home Prod |
Process for the uniform distribution of a drug on a granulated base
|
|
FR2183546B1
(forum.php)
|
1972-05-10 |
1975-06-20 |
Servier Lab |
|
|
US3963832A
(en)
|
1973-01-24 |
1976-06-15 |
Teijin Limited |
Liquid or pasty dentifrice and process for its preparation
|
|
JPS5512411B2
(forum.php)
|
1974-03-12 |
1980-04-02 |
|
|
|
US4013820A
(en)
|
1974-11-07 |
1977-03-22 |
Abbott Laboratories |
Universally useable tableting ingredients
|
|
US4036228A
(en)
|
1975-09-11 |
1977-07-19 |
Alza Corporation |
Osmotic dispenser with gas generating means
|
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
US4332789A
(en)
|
1975-12-15 |
1982-06-01 |
Hoffmann-La Roche Inc. |
Pharmaceutical unit dosage forms
|
|
US4344857A
(en)
|
1975-12-22 |
1982-08-17 |
The United States Of America As Represented By The Secretary Of Agriculture |
Encapsulation by entrapment
|
|
US4126672A
(en)
|
1976-02-04 |
1978-11-21 |
Hoffmann-La Roche Inc. |
Sustained release pharmaceutical capsules
|
|
US4167558A
(en)
|
1976-02-13 |
1979-09-11 |
Hoffmann-La Roche Inc. |
Novel sustained release tablet formulations
|
|
US4140755A
(en)
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
|
US4101650A
(en)
|
1977-04-06 |
1978-07-18 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Pepstatin floating minicapsules
|
|
US4163777A
(en)
|
1977-04-29 |
1979-08-07 |
Lewis/Howe Company |
Controlled antacid delivery form and method of treatment therewith
|
|
GB1579818A
(en)
|
1977-06-07 |
1980-11-26 |
Yamanouchi Pharma Co Ltd |
Nifedipine-containing solid preparation composition
|
|
US4361545A
(en)
|
1979-05-21 |
1982-11-30 |
Rowell Laboratories, Inc. |
Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4248858A
(en)
|
1979-08-09 |
1981-02-03 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
US4309405A
(en)
|
1979-08-09 |
1982-01-05 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
FR2470599A1
(fr)
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
US4259314A
(en)
|
1979-12-10 |
1981-03-31 |
Hans Lowey |
Method and composition for the preparation of controlled long-acting pharmaceuticals
|
|
US4308251A
(en)
|
1980-01-11 |
1981-12-29 |
Boots Pharmaceuticals, Inc. |
Controlled release formulations of orally-active medicaments
|
|
US4344929A
(en)
|
1980-04-25 |
1982-08-17 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4620007A
(en)
|
1980-09-03 |
1986-10-28 |
Bayer Aktiengesellschaft |
6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
|
|
US4670444B1
(en)
|
1980-09-03 |
1999-02-09 |
Bayer Ag |
and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
|
|
US4439453A
(en)
|
1980-12-22 |
1984-03-27 |
Monsanto Company |
Directly compressible acetaminophen granulation
|
|
DE3127237A1
(de)
|
1981-07-10 |
1983-01-20 |
Hoechst Ag, 6000 Frankfurt |
Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
|
|
US4375468A
(en)
|
1981-07-13 |
1983-03-01 |
Verex Laboratories, Inc. |
Constant order release aspirin composition and method of treating arthritis
|
|
US4424235A
(en)
|
1981-09-14 |
1984-01-03 |
Hoffmann-La Roche Inc. |
Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
|
|
JPS5846019A
(ja)
|
1981-09-14 |
1983-03-17 |
Kanebo Ltd |
持続性ニフエジピン製剤
|
|
US4369172A
(en)
|
1981-12-18 |
1983-01-18 |
Forest Laboratories Inc. |
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
|
|
US4525345A
(en)
|
1981-12-24 |
1985-06-25 |
Verex Laboratories, Inc. |
Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
|
|
US4434153A
(en)
|
1982-03-22 |
1984-02-28 |
Alza Corporation |
Drug delivery system comprising a reservoir containing a plurality of tiny pills
|
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
US4414198A
(en)
|
1982-04-23 |
1983-11-08 |
Joseph Michaelson |
Rapidly disintegrable tablet composition and method
|
|
US4556678A
(en)
|
1982-06-24 |
1985-12-03 |
Key Pharmaceuticals, Inc. |
Sustained release propranolol tablet
|
|
US4444769A
(en)
|
1982-07-27 |
1984-04-24 |
Mylan Pharmaceuticals, Inc. |
Antihypertensive diuretic combination composition and associated method
|
|
ATE51147T1
(de)
|
1982-07-27 |
1990-04-15 |
Mylan Pharmaceuticals Inc |
Verfahren zur herstellung einer kombinierten pharmazeutischen zusammensetzung in einer granulaeren heterogenen dosisform mit erhoehter bioverfuegbarkeit.
|
|
US5366738A
(en)
|
1982-07-29 |
1994-11-22 |
Merck & Co., Inc. |
Controlled release drug dispersion delivery device
|
|
CA1207231A
(en)
|
1982-08-24 |
1986-07-08 |
Hans W. Zulliger |
Medicated suppository
|
|
US4698101A
(en)
|
1982-08-30 |
1987-10-06 |
Suomen Sokeri Oy (Finnish Sugar Company Ltd.) |
Binder-diluent composition and method
|
|
US4547498A
(en)
|
1983-01-06 |
1985-10-15 |
Mylan Pharmaceuticals Inc. |
Pharmaceutical combination composition and associated method
|
|
US4526777A
(en)
|
1983-01-06 |
1985-07-02 |
Mylan Pharmaceuticals Inc. |
Pharmaceutical combination composition and associated method
|
|
DE3435325A1
(de)
|
1983-04-09 |
1986-04-17 |
Nikken Chemicals Co., Ltd., Tokio/Tokyo |
Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
|
|
DE3318649A1
(de)
|
1983-05-21 |
1984-11-22 |
Bayer Ag, 5090 Leverkusen |
Zweiphasenformulierung
|
|
GB8323624D0
(en)
|
1983-09-02 |
1983-10-05 |
Reckitt & Colmann Prod Ltd |
Medicinal compositions
|
|
DE3333719A1
(de)
|
1983-09-17 |
1985-04-04 |
Bayer Ag |
Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
|
|
US4717713A
(en)
|
1983-10-31 |
1988-01-05 |
Research Corporation |
Controlled release liquid pharmaceutical
|
|
DE3346571A1
(de)
|
1983-12-23 |
1985-07-04 |
Bayer Ag, 5090 Leverkusen |
Oral retardierte acetylsalicylsaeureformulierungen
|
|
US4613497A
(en)
*
|
1984-02-29 |
1986-09-23 |
Health Products Development, Inc. |
Dry, water-foamable pharmaceutical compositions
|
|
US4849229A
(en)
|
1984-03-26 |
1989-07-18 |
Forest Laboratories, Inc. |
Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
|
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
|
JPS60219238A
(ja)
|
1984-04-14 |
1985-11-01 |
Hayashibara Biochem Lab Inc |
徐崩性プルラン含有成形物とその製法
|
|
US4590062A
(en)
|
1984-04-16 |
1986-05-20 |
Tech Trade Corp. |
Dry direct compression compositions for controlled release dosage forms
|
|
JPS60174728U
(ja)
|
1984-04-26 |
1985-11-19 |
山田 喜一 |
消雪屋根の構造
|
|
DE3420116A1
(de)
|
1984-05-30 |
1985-12-05 |
Bayer Ag, 5090 Leverkusen |
Immunstimulierende mittel
|
|
DE3420770A1
(de)
|
1984-06-04 |
1985-12-05 |
Bayer Ag, 5090 Leverkusen |
1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
|
|
JPS6124516A
(ja)
|
1984-07-12 |
1986-02-03 |
Fujisawa Pharmaceut Co Ltd |
持続性錠剤
|
|
JPS6143108A
(ja)
|
1984-08-03 |
1986-03-01 |
Nippon Shinyaku Co Ltd |
医薬品製剤及びその製造法
|
|
US4610870A
(en)
|
1984-10-05 |
1986-09-09 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
GB8426152D0
(en)
|
1984-10-16 |
1984-11-21 |
Reckitt & Colmann Prod Ltd |
Medicinal compositions
|
|
DE3440288C2
(de)
|
1984-11-05 |
1987-03-12 |
Gergely, Gerhard, Dr.-Ing., Wien |
Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
|
|
BE901111A
(fr)
|
1984-11-22 |
1985-03-15 |
Benfar Representee Par Vanderl |
Composition pharmaceutiques a liberation prolongee, leur procede de preparation et leur utilisation.
|
|
EP0182772A3
(fr)
|
1984-11-22 |
1987-04-01 |
Benfar |
Compositions pharmaceutiques à libération prolongée, leur procédé de préparation et leur utilisation
|
|
US4839171A
(en)
|
1984-11-30 |
1989-06-13 |
Techmix, Inc. |
Composition for treating impaired lactation
|
|
DE3517709A1
(de)
|
1985-01-05 |
1986-07-10 |
Bayer Ag |
Basische zubereitungen von chinoloncarbonsaeuren
|
|
EP0188040B1
(en)
|
1985-01-11 |
1991-08-14 |
Abbott Laboratories Limited |
Slow release solid preparation
|
|
US4639458A
(en)
|
1985-01-22 |
1987-01-27 |
Merck & Co., Inc. |
Tablet and formulation
|
|
US4747881A
(en)
|
1985-02-05 |
1988-05-31 |
Warner-Lambert Company |
Ingestible aggregate and delivery system prepared therefrom
|
|
DE3504643A1
(de)
|
1985-02-12 |
1986-08-14 |
Bayer Ag, 5090 Leverkusen |
1-cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl)-3-chinolin carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
|
|
DE3509546A1
(de)
|
1985-03-16 |
1986-09-25 |
Bayer Ag, 5090 Leverkusen |
7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
|
|
GB8507779D0
(en)
|
1985-03-26 |
1985-05-01 |
Fujisawa Pharmaceutical Co |
Drug carrier
|
|
DK162986A
(da)
|
1985-04-12 |
1986-10-13 |
Forest Laboratories |
Terapeutisk middel i enhedsdosisform
|
|
DE3517535A1
(de)
|
1985-05-15 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
1-aryl-4-chinolon-3-carbonsaeuren
|
|
US4695463A
(en)
|
1985-05-24 |
1987-09-22 |
Warner-Lambert Company |
Delivery system for active ingredients and preparation thereof
|
|
US4666705A
(en)
|
1985-06-03 |
1987-05-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
DE3681348D1
(de)
|
1985-06-11 |
1991-10-17 |
Teijin Ltd |
Oral-arzneizubereitung mit retardwirkung.
|
|
EP0227814A1
(en)
|
1985-07-02 |
1987-07-08 |
The Upjohn Company |
Therapeutic formulations with bimodal release characteristics
|
|
DE3608745A1
(de)
|
1985-07-24 |
1987-01-29 |
Bayer Ag |
Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
|
|
GB8518927D0
(en)
|
1985-07-26 |
1985-09-04 |
Vincent Processes Ltd |
Tablets
|
|
GB8522453D0
(en)
|
1985-09-11 |
1985-10-16 |
Lilly Industries Ltd |
Chewable capsules
|
|
JPS62103012A
(ja)
|
1985-10-23 |
1987-05-13 |
Eisai Co Ltd |
多重顆粒
|
|
DE3537761A1
(de)
|
1985-10-24 |
1987-04-30 |
Bayer Ag |
Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
|
|
US4734285A
(en)
|
1985-10-28 |
1988-03-29 |
The Dow Chemical Company |
Sustained release compositions
|
|
US4704285A
(en)
|
1985-11-18 |
1987-11-03 |
The Dow Chemical Company |
Sustained release compositions comprising hydroxypropyl cellulose ethers
|
|
US4977154A
(en)
|
1985-12-12 |
1990-12-11 |
Warner-Lambert Company |
5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
|
|
IT1188212B
(it)
|
1985-12-20 |
1988-01-07 |
Paolo Colombo |
Sistema per il rilascio a velocita' controllata di sostanze attive
|
|
GB8601204D0
(en)
|
1986-01-18 |
1986-02-19 |
Boots Co Plc |
Therapeutic agents
|
|
US5286754A
(en)
|
1986-01-21 |
1994-02-15 |
Bayer Aktiengesellschaft |
Pharmaceutical formulations of ciprofloxacin
|
|
IE63321B1
(en)
|
1986-02-03 |
1995-04-05 |
Elan Corp Plc |
Drug delivery system
|
|
GB2186485B
(en)
|
1986-02-13 |
1988-09-07 |
Ethical Pharma Ltd |
Slow release formulation
|
|
DE3705621C2
(de)
|
1986-02-25 |
1997-01-09 |
Otsuka Pharma Co Ltd |
Heterocyclisch substituierte Chinoloncarbonsäurederivate
|
|
IT1191674B
(it)
|
1986-03-07 |
1988-03-23 |
Eurand Spa |
Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
|
|
GB8608818D0
(en)
|
1986-04-11 |
1986-05-14 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
|
US4798725A
(en)
|
1986-06-16 |
1989-01-17 |
Norwich Eaton Pharmaceuticals, Inc. |
Sustained release capsule
|
|
US4847093A
(en)
|
1986-06-19 |
1989-07-11 |
Alza Corporation |
Dosage form with means for governing rate of gas formation
|
|
JPH0798742B2
(ja)
|
1986-07-03 |
1995-10-25 |
ゼリア新薬工業株式会社 |
徐放性製剤組成物
|
|
JPH0826346B2
(ja)
|
1986-07-10 |
1996-03-13 |
株式会社林原生物化学研究所 |
固状油溶性物質の製法
|
|
GB8618847D0
(en)
|
1986-08-01 |
1986-09-10 |
Smith Kline French Lab |
Pharmaceutical formulations
|
|
US4800083A
(en)
|
1986-10-20 |
1989-01-24 |
R. P. Scherer Corporation |
Sustained release method and product
|
|
DE3636123A1
(de)
|
1986-10-23 |
1988-05-05 |
Rentschler Arzneimittel |
Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
|
|
GB8628359D0
(en)
|
1986-11-27 |
1986-12-31 |
Zyma Sa |
Galenical formulation
|
|
ES2040697T3
(es)
|
1986-12-18 |
1993-11-01 |
Kurt H. Prof. Dr. Bauer |
Concentrado de nifedipina estabilizado frente a la influencia de la luz, y procedimiento para su preparacion.
|
|
IE59540B1
(en)
|
1987-01-09 |
1994-03-09 |
Elan Corp |
Sustained release capsule or tablet formulation
|
|
US5015479A
(en)
|
1987-02-02 |
1991-05-14 |
Seamus Mulligan |
Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
|
|
GB8705083D0
(en)
|
1987-03-04 |
1987-04-08 |
Euro Celtique Sa |
Spheroids
|
|
US4786503A
(en)
|
1987-04-06 |
1988-11-22 |
Alza Corporation |
Dosage form comprising parallel lamine
|
|
US4808413A
(en)
|
1987-04-28 |
1989-02-28 |
E. R. Squibb & Sons, Inc. |
Pharmaceutical compositions in the form of beadlets and method
|
|
KR960011236B1
(ko)
|
1987-05-08 |
1996-08-21 |
스미스 클라인 앤드 프렌취 라보라토리스 리미티드 |
제약학적 조성물 및 고체 제형
|
|
DE3719764A1
(de)
|
1987-06-13 |
1988-12-22 |
Bayer Ag |
Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
|
|
DE3720757A1
(de)
|
1987-06-24 |
1989-01-05 |
Bayer Ag |
Dhp-manteltablette
|
|
US5219575A
(en)
|
1987-06-26 |
1993-06-15 |
Duphar International Research B.V. |
Compositions with controlled zero-order delivery rate and method of preparing these compositions
|
|
US4814178A
(en)
|
1987-07-01 |
1989-03-21 |
Sanford Bolton |
Floating sustained release therapeutic compositions
|
|
US4792452A
(en)
|
1987-07-28 |
1988-12-20 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4803205A
(en)
|
1987-08-07 |
1989-02-07 |
Warner-Lambert Company |
Quinolones as antibacterial agents
|
|
US4994276A
(en)
|
1988-09-19 |
1991-02-19 |
Edward Mendell Co., Inc. |
Directly compressible sustained release excipient
|
|
GB8722306D0
(en)
|
1987-09-22 |
1987-10-28 |
Aps Research Ltd |
Sustained-release formulation
|
|
SE8703881D0
(sv)
|
1987-10-08 |
1987-10-08 |
Haessle Ab |
New pharmaceutical preparation
|
|
GB8723896D0
(en)
|
1987-10-12 |
1987-11-18 |
Aps Research Ltd |
Controlled-release formulation
|
|
US5023245A
(en)
|
1987-11-10 |
1991-06-11 |
Hauser-Kuhrts, Inc. |
Improved niacin formulation
|
|
US5466469A
(en)
|
1988-06-28 |
1995-11-14 |
Cibus Pharmaceutical, Inc. |
Granular drug delivery system
|
|
US4965252A
(en)
|
1988-06-28 |
1990-10-23 |
Hauser-Kuhrts, Inc. |
Cholesterol-lowering combination compositions of guar gum and niacin
|
|
DE3803482A1
(de)
|
1988-02-05 |
1989-08-17 |
Lohmann Therapie Syst Lts |
Schwimmfaehiges orales therapeutisches system
|
|
US5133090A
(en)
|
1988-02-11 |
1992-07-28 |
The Trustees Of Columbia University In The City Of New York |
Antiviral glove
|
|
US5019096A
(en)
|
1988-02-11 |
1991-05-28 |
Trustees Of Columbia University In The City Of New York |
Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
|
|
JP2668730B2
(ja)
|
1988-03-09 |
1997-10-27 |
雪印乳業株式会社 |
天然ポリマーを用いた徐放性製剤
|
|
DE3902079A1
(de)
|
1988-04-15 |
1989-10-26 |
Bayer Ag |
I.m. injektionsformen von gyrase-inhibitoren
|
|
US5271946A
(en)
|
1988-04-20 |
1993-12-21 |
Asta Pharma Aktiengesellschaft |
Controlled release azelastine-containing pharmaceutical compositions
|
|
US4931285A
(en)
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
|
US5002772A
(en)
|
1988-05-31 |
1991-03-26 |
Pfizer Inc. |
Gastric retention system for controlled drug release
|
|
US5445826A
(en)
|
1988-06-28 |
1995-08-29 |
Cibus Pharmaceutical, Inc. |
Delivery system containing a gel-forming dietary fiber and a drug
|
|
US5096714A
(en)
|
1988-06-28 |
1992-03-17 |
Hauser-Kuhrts, Inc. |
Prolonged release drug tablet formulations
|
|
FR2634376B1
(fr)
|
1988-07-21 |
1992-04-17 |
Farmalyoc |
Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
|
|
US5225413A
(en)
|
1988-09-16 |
1993-07-06 |
Bayer-Aktiengesellschaft |
pH-neutral aqueous solutions of quinolone-carboxylic acids
|
|
US5135757A
(en)
|
1988-09-19 |
1992-08-04 |
Edward Mendell Co., Inc. |
Compressible sustained release solid dosage forms
|
|
US5128143A
(en)
|
1988-09-19 |
1992-07-07 |
Edward Mendell Co., Inc. |
Sustained release excipient and tablet formulation
|
|
US5169639A
(en)
|
1988-09-19 |
1992-12-08 |
Edward Mendell Co., Inc. |
Controlled release verapamil tablets
|
|
US4978661A
(en)
|
1988-09-29 |
1990-12-18 |
Innocenzo Caruso |
Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
|
|
US5256699A
(en)
|
1988-10-18 |
1993-10-26 |
Ciba-Geify Corporation |
Dispersible tablet formulation of diclofenac acid free base
|
|
GB8903328D0
(en)
|
1989-02-14 |
1989-04-05 |
Ethical Pharma Ltd |
Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
|
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
US5126145A
(en)
|
1989-04-13 |
1992-06-30 |
Upsher Smith Laboratories Inc |
Controlled release tablet containing water soluble medicament
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US4973470A
(en)
|
1989-06-26 |
1990-11-27 |
Warner-Lambert Company |
Sustained release pharmaceutical compositions
|
|
US5082669A
(en)
|
1989-07-20 |
1992-01-21 |
Dainippon Pharmaceutical Co., Ltd. |
Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
|
|
US5219574A
(en)
|
1989-09-15 |
1993-06-15 |
Cima Labs. Inc. |
Magnesium carbonate and oil tableting aid and flavoring additive
|
|
EP0418596A3
(en)
|
1989-09-21 |
1991-10-23 |
American Cyanamid Company |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
|
|
US5178878A
(en)
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5223264A
(en)
|
1989-10-02 |
1993-06-29 |
Cima Labs, Inc. |
Pediatric effervescent dosage form
|
|
FR2655545B1
(fr)
|
1989-12-11 |
1994-06-10 |
Rhone Poulenc Sante |
Nouvelle application therapeutique des derives des fluoroquinolones.
|
|
US4992449A
(en)
|
1990-02-01 |
1991-02-12 |
American Cyanamid Company |
7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
|
|
US5084276A
(en)
|
1990-01-05 |
1992-01-28 |
Abbott Laboratories |
Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
|
|
US5198227A
(en)
|
1990-01-22 |
1993-03-30 |
Mcneil-Ppc, Inc. |
Dual subcoated simulated capsule medicament
|
|
US5009895A
(en)
|
1990-02-02 |
1991-04-23 |
Merck & Co., Inc. |
Sustained release with high and low viscosity HPMC
|
|
US5256662A
(en)
|
1990-04-12 |
1993-10-26 |
Warner-Lambert Company |
Quinolinecarboxylic acid antibacterial agents
|
|
DK0537139T3
(da)
|
1990-07-02 |
1994-08-22 |
Boehringer Mannheim Gmbh |
Fremgangsmåde til fremstilling af formede, pressede dosisenheder med forsinket frigørelse og dertil svarende dosisenhed
|
|
IT1246350B
(it)
|
1990-07-11 |
1994-11-17 |
Eurand Int |
Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
|
|
GB9022788D0
(en)
|
1990-10-19 |
1990-12-05 |
Cortecs Ltd |
Pharmaceutical formulations
|
|
SE9003904D0
(sv)
|
1990-12-07 |
1990-12-07 |
Astra Ab |
Method for the manufacture of a pharmaceutical dosage form
|
|
US5232704A
(en)
|
1990-12-19 |
1993-08-03 |
G. D. Searle & Co. |
Sustained release, bilayer buoyant dosage form
|
|
US5198229A
(en)
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
|
YU48263B
(sh)
|
1991-06-17 |
1997-09-30 |
Byk Gulden Lomberg Chemische Fabrik Gmbh. |
Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
|
|
US5464632C1
(en)
|
1991-07-22 |
2001-02-20 |
Prographarm Lab |
Rapidly disintegratable multiparticular tablet
|
|
US5225201A
(en)
|
1991-08-23 |
1993-07-06 |
Minnesota Mining And Manufacturing Company |
Salsalate tablet
|
|
FI93924C
(fi)
|
1991-09-17 |
1995-06-26 |
Martti Lauri Antero Marvola |
Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
|
|
JPH0624959A
(ja)
*
|
1991-10-04 |
1994-02-01 |
Bayer Yakuhin Kk |
胃内浮遊型薬物徐放性固形製剤
|
|
US5169638A
(en)
|
1991-10-23 |
1992-12-08 |
E. R. Squibb & Sons, Inc. |
Buoyant controlled release powder formulation
|
|
EP0546593B1
(en)
|
1991-10-30 |
1997-09-03 |
Glaxo Group Limited |
Multi-layered compositions containing histamine or serotonin antagonists
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
DE4200821A1
(de)
|
1992-01-15 |
1993-07-22 |
Bayer Ag |
Geschmacksmaskierte pharmazeutische mittel
|
|
KR0159540B1
(ko)
|
1992-01-21 |
1998-12-01 |
김정순 |
퀴놀론-카복실산의 염 및 그 함유조성물
|
|
US5429822A
(en)
|
1992-03-13 |
1995-07-04 |
Cambridge Scientific, Inc. |
Biodegradable bursting release system
|
|
US5582837A
(en)
|
1992-03-25 |
1996-12-10 |
Depomed, Inc. |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
|
|
US5292534A
(en)
|
1992-03-25 |
1994-03-08 |
Valentine Enterprises, Inc. |
Sustained release composition and method utilizing xanthan gum and an active ingredient
|
|
US5518730A
(en)
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
|
US5288507A
(en)
|
1992-07-29 |
1994-02-22 |
Merck & Co., Inc. |
Ibuprofen antacid combinations
|
|
US5472711A
(en)
|
1992-07-30 |
1995-12-05 |
Edward Mendell Co., Inc. |
Agglomerated hydrophilic complexes with multi-phasic release characteristics
|
|
IT1255522B
(it)
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
IT1256393B
(it)
|
1992-11-17 |
1995-12-04 |
Inverni Della Beffa Spa |
Forme matriciali multistrato per il rilascio controllato di principi attivi
|
|
TW235239B
(forum.php)
|
1992-11-20 |
1994-12-01 |
Pfizer |
|
|
GB9224855D0
(en)
|
1992-11-27 |
1993-01-13 |
Smithkline Beecham Plc |
Pharmaceutical compositions
|
|
FR2699076A1
(fr)
|
1992-12-11 |
1994-06-17 |
Colgate Palmolive Co |
Forme pharmaceutique et procédé pour délivrer un ingrédient actif à une poche parodontale.
|
|
GB2273874A
(en)
|
1992-12-31 |
1994-07-06 |
Pertti Olavi Toermaelae |
Preparation of pharmaceuticals in a polymer matrix
|
|
US5340572A
(en)
|
1993-02-08 |
1994-08-23 |
Insite Vision Incorporated |
Alkaline ophthalmic suspensions
|
|
US6034100A
(en)
|
1993-03-10 |
2000-03-07 |
Otsuka Pharmaceutical Co., Ltd. |
Method for inhibiting cytokine secretion
|
|
US5503846A
(en)
|
1993-03-17 |
1996-04-02 |
Cima Labs, Inc. |
Base coated acid particles and effervescent formulation incorporating same
|
|
IT1264517B1
(it)
|
1993-05-31 |
1996-09-24 |
Ekita Investments Nv |
Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
|
|
IT1264696B1
(it)
|
1993-07-09 |
1996-10-04 |
Applied Pharma Res |
Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
|
US5662933A
(en)
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
|
US5455046A
(en)
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
|
US5631004A
(en)
|
1993-09-30 |
1997-05-20 |
Alcon Laboratories, Inc. |
Use of sustained release antibiotic compositions in ophthalmic surgical procedures
|
|
FR2711524B1
(fr)
|
1993-10-21 |
1995-11-24 |
Rhone Dpc Europ |
Procédé de préparation de compositions orales contenant des quinolones.
|
|
FR2711525B1
(fr)
|
1993-10-29 |
1996-01-12 |
Virbac Laboratoires |
Forme Galénique à administration orale pour animaux, son procédé de préparation et ses applications.
|
|
US5888540A
(en)
|
1993-10-29 |
1999-03-30 |
Sugden; Keith |
Pharmaceutical products
|
|
US5399358A
(en)
|
1993-11-12 |
1995-03-21 |
Edward Mendell Co., Inc. |
Sustained release formulations for 24 hour release of metroprolol
|
|
US5419917A
(en)
|
1994-02-14 |
1995-05-30 |
Andrx Pharmaceuticals, Inc. |
Controlled release hydrogel formulation
|
|
DE4406424A1
(de)
|
1994-02-28 |
1995-08-31 |
Bayer Ag |
Expandierbare Arzneiformen
|
|
US5399359A
(en)
|
1994-03-04 |
1995-03-21 |
Edward Mendell Co., Inc. |
Controlled release oxybutynin formulations
|
|
JPH07251130A
(ja)
|
1994-03-11 |
1995-10-03 |
Kansai Paint Co Ltd |
撥水性塗膜形成方法
|
|
JP2917799B2
(ja)
|
1994-03-11 |
1999-07-12 |
田辺製薬株式会社 |
消化管内適所放出型製剤
|
|
US5399362A
(en)
|
1994-04-25 |
1995-03-21 |
Edward Mendell Co., Inc. |
Once-a-day metoprolol oral dosage form
|
|
DE19509807A1
(de)
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
|
US5464633A
(en)
|
1994-05-24 |
1995-11-07 |
Jagotec Ag |
Pharmaceutical tablets releasing the active substance after a definite period of time
|
|
US5567439A
(en)
|
1994-06-14 |
1996-10-22 |
Fuisz Technologies Ltd. |
Delivery of controlled-release systems(s)
|
|
IL114193A
(en)
|
1994-06-20 |
2000-02-29 |
Teva Pharma |
Ophthalmic pharmaceutical compositions based on sodium alginate
|
|
US5733575A
(en)
|
1994-10-07 |
1998-03-31 |
Bpsi Holdings, Inc. |
Enteric film coating compositions, method of coating therewith, and coated forms
|
|
US5728402A
(en)
|
1994-11-16 |
1998-03-17 |
Andrx Pharmaceuticals Inc. |
Controlled release formulation of captopril or a prodrug of captopril
|
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
|
IL139728A
(en)
|
1995-01-09 |
2003-06-24 |
Penwest Pharmaceuticals Compan |
Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
|
|
FR2729857B1
(fr)
|
1995-01-27 |
1997-04-04 |
Rhone Poulenc Chimie |
Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
|
|
US5534263A
(en)
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
|
US5695781A
(en)
|
1995-03-01 |
1997-12-09 |
Hallmark Pharmaceuticals, Inc. |
Sustained release formulation containing three different types of polymers
|
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
|
US5900425A
(en)
|
1995-05-02 |
1999-05-04 |
Bayer Aktiengesellschaft |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US5624677A
(en)
|
1995-06-13 |
1997-04-29 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
|
US5560928A
(en)
|
1995-06-23 |
1996-10-01 |
Defelice; Stephen L. |
Nutritional and/or dietary composition and method of using the same
|
|
US6132768A
(en)
|
1995-07-05 |
2000-10-17 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
|
|
US5945124A
(en)
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
|
ES2105970B1
(es)
|
1995-08-02 |
1998-07-01 |
S A L V A T Lab Sa |
Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas.
|
|
ES2106680B1
(es)
|
1995-08-03 |
1998-07-01 |
Vita Invest Sa |
Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
|
|
US5773019A
(en)
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
|
US5811126A
(en)
|
1995-10-02 |
1998-09-22 |
Euro-Celtique, S.A. |
Controlled release matrix for pharmaceuticals
|
|
DE19539361A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
|
US5686095A
(en)
|
1995-10-23 |
1997-11-11 |
Price, Jr.; Francis W. |
Method of treating canker sores
|
|
US5733578A
(en)
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
|
US5705190A
(en)
|
1995-12-19 |
1998-01-06 |
Abbott Laboratories |
Controlled release formulation for poorly soluble basic drugs
|
|
WO1997026865A1
(en)
|
1996-01-29 |
1997-07-31 |
Edward Mendell Co., Inc. |
Sustained release excipient
|
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
|
US6096339A
(en)
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
|
US5858409A
(en)
|
1996-04-17 |
1999-01-12 |
Fmc Corporation |
Hydrolyzed cellulose granulations for pharmaceuticals
|
|
US5837292A
(en)
|
1996-07-03 |
1998-11-17 |
Yamanouchi Europe B.V. |
Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
|
|
CA2262595C
(en)
|
1996-08-15 |
2005-10-18 |
Losan Pharma Gmbh |
Easy to swallow oral medicament composition
|
|
US6503881B2
(en)
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
|
ES2565163T3
(es)
|
1996-10-28 |
2016-03-31 |
General Mills, Inc. |
Imbibición y encapsulación de partículas de liberación controlada y producto encapsulado
|
|
US5807580A
(en)
|
1996-10-30 |
1998-09-15 |
Mcneil-Ppc, Inc. |
Film coated tablet compositions having enhanced disintegration characteristics
|
|
US5759579A
(en)
|
1996-12-05 |
1998-06-02 |
American Home Products Corporation |
Pharmaceutical suspension systems
|
|
CA2227314A1
(en)
|
1997-01-24 |
1998-07-24 |
Hoechst Aktiengesellschaft |
Preparation of concealed taste preparations of antibacterially active quinolone derivatives
|
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
|
DE19706978A1
(de)
|
1997-02-21 |
1998-08-27 |
Ulrich Dr Posanski |
Kombinationspräparat für oral applizierbare Antibiotika
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
DE19710213A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
|
US5728401A
(en)
|
1997-04-16 |
1998-03-17 |
Ranbaxy Laboratories, Ltd. |
Effervescent ranitidine formulations
|
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
WO1999007342A1
(en)
|
1997-08-11 |
1999-02-18 |
Alza Corporation |
Prolonged release active agent dosage form adapted for gastric retention
|
|
TW477702B
(en)
|
1997-10-23 |
2002-03-01 |
Dev Center Biotechnology |
Controlled release tacrine dosage form
|
|
US6017912A
(en)
|
1998-02-27 |
2000-01-25 |
Bussell; Letantia |
Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
|
|
US6174524B1
(en)
|
1999-03-26 |
2001-01-16 |
Alcon Laboratories, Inc. |
Gelling ophthalmic compositions containing xanthan gum
|